Business

Ventripoint Clarifies News Release of December 17, 2019

(via TheNewswire) Toronto, Ontario - TheNewswire - December 19, 2019 - Ven...

articleVentripoint Diagnostics Ltd.December 19, 20194/company/ventripoint-diagnostics-ltd/news/ventripoint-clarifies-news-release-of-december-17-2019
Ventripoint Clarifies News Release of December 17, 2019

About this update from Ventripoint Diagnostics Ltd.

[{"type":"text","content":"Ventripoint Clarifies News Release of December 17, 2019(via TheNewswire)\n \n \nToronto, Ontario - TheNewswire - December 19, 2019 - Ventripoint Diagnostics Ltd. (\"Ventripoint\" or the \"Company\") (TSXV:VPT) (OTC:VPTDF) wishes to clarify the news release of December 17, 2019. \n\n\n \nThe Company is not in receivership and it has not made an assignment under the Bankruptcy and Insolvency Act. The Company is organizing a private placement and expects to resume normal operations in the new year.\n\n\n \nAbout Ventripoint Diagnostics Ltd.\n\n\n \nVentripoint's technology is a leading Artificial Intelligence (AI) approach known as Knowledge-Based Reconstruction (KBR), used to create applications to monitor heart disease, a leading cause of death worldwide. The VMS+ is the first cost-effective and accurate tool for measuring whole heart function using conventional ultrasound. The Company has developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac care. For further information please contact:\n\n\n \nDr. George Adams, Executive-Chairman\nTelephone: (519) 803-6937\n\n\n \nEmail: [email protected]\n\n\n \nForward Looking Statements:\n\n\n \nThis news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words \"expect\", \"anticipate\", \"continue\", \"estimate\", \"objective\", \"ongoing\", \"may\", \"will\", \"project\", \"should\", \"believe\", \"plans\", \"intends\" and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Corporation. Although the Corporation believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Corporation can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Other f...

More updates from Ventripoint Diagnostics Ltd.